HU9301856D0 - Application of glutarimide derivatives for treating depressive and maniacal diseases - Google Patents

Application of glutarimide derivatives for treating depressive and maniacal diseases

Info

Publication number
HU9301856D0
HU9301856D0 HU931856V HUP9301856V HU9301856D0 HU 9301856 D0 HU9301856 D0 HU 9301856D0 HU 931856 V HU931856 V HU 931856V HU P9301856 V HUP9301856 V HU P9301856V HU 9301856 D0 HU9301856 D0 HU 9301856D0
Authority
HU
Hungary
Prior art keywords
maniacal
diseases
application
treating depressive
glutarimide derivatives
Prior art date
Application number
HU931856V
Other languages
English (en)
Hungarian (hu)
Inventor
Marcel Hibert
Maurice W Gittos
Original Assignee
Merrell Dow Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merrell Dow Pharma filed Critical Merrell Dow Pharma
Publication of HU9301856D0 publication Critical patent/HU9301856D0/hu

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/45—Non condensed piperidines, e.g. piperocaine having oxo groups directly attached to the heterocyclic ring, e.g. cycloheximide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Neurology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Psychiatry (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrrole Compounds (AREA)
HU931856V 1990-12-24 1991-12-02 Application of glutarimide derivatives for treating depressive and maniacal diseases HU9301856D0 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP90403757 1990-12-24

Publications (1)

Publication Number Publication Date
HU9301856D0 true HU9301856D0 (en) 1993-09-28

Family

ID=8205790

Family Applications (1)

Application Number Title Priority Date Filing Date
HU931856V HU9301856D0 (en) 1990-12-24 1991-12-02 Application of glutarimide derivatives for treating depressive and maniacal diseases

Country Status (7)

Country Link
EP (1) EP0564520A1 (fr)
JP (1) JPH06504279A (fr)
KR (1) KR930702976A (fr)
AU (1) AU9134191A (fr)
CA (1) CA2097607A1 (fr)
HU (1) HU9301856D0 (fr)
WO (1) WO1992011011A1 (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2552929C1 (ru) * 2013-11-14 2015-06-10 Общество С Ограниченной Ответственностью "Фарминтерпрайсез" Фармацевтическая композиция, содержащая производные глутаримидов, и их применение для лечения эозинофильных заболеваний

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4361565A (en) * 1981-12-28 1982-11-30 Mead Johnson & Company 2-[4-[(4,4-Dialkyl-2,6-piperidinedion-1-yl)butyl]-1-piperazinyl]pyridines
AR241161A1 (es) * 1984-07-30 1991-12-30 Merrelll Dow Pharmaceuticals I "procedimiento para la preparacion de derivados n-aminoalquilen sustituidos de la glutarimida"
AU583343B2 (en) * 1985-01-23 1989-04-27 Glaxo Group Limited Heterocyclic compounds
US4748182A (en) * 1986-03-05 1988-05-31 Merrell Dow Pharmaceuticals Inc. Aromatic 2-aminoalkyl-1,2-benzoisothiazol-3(2H)one-1,1-dioxide derivatives and their use as anti-hypertensive and anxiolytic agents
US4788290A (en) * 1987-12-11 1988-11-29 American Home Products Corporation Serotonergic pyrazine derivatives
DE3831888A1 (de) * 1988-09-20 1990-03-29 Troponwerke Gmbh & Co Kg Arzneimittel zur behandlung von apoplexia cerebri
EP0375819A1 (fr) * 1988-12-20 1990-07-04 Merrell Dow Pharmaceuticals Inc. Dérivés de 1,7'-[imidazo-[1,2-a]pyridin]5'-(6'H)ones

Also Published As

Publication number Publication date
CA2097607A1 (fr) 1992-06-24
WO1992011011A1 (fr) 1992-07-09
KR930702976A (ko) 1993-11-29
EP0564520A1 (fr) 1993-10-13
JPH06504279A (ja) 1994-05-19
AU9134191A (en) 1992-07-22

Similar Documents

Publication Publication Date Title
HU9402817D0 (en) Compounds for treating allergic and inflammatory diseases
GB9027968D0 (en) Method of treatment
GB8921304D0 (en) New method of treatment and heterocyclic compounds used therein
GB9014307D0 (en) Method of treatment and compositions therefor
GB2271579B (en) Treatment of wood
GB9218027D0 (en) Novel method of treatment
HU9301856D0 (en) Application of glutarimide derivatives for treating depressive and maniacal diseases
ZA915682B (en) Method of treatment of allergic conjunctivitis
GB9202196D0 (en) Method of treatment
ZA938897B (en) Antioxidant neuroprotective use of and method of treatment using hydroxycarbazole compounds
GB9317943D0 (en) Treatment of laminitis
CS61691A2 (en) Composition for dung-water treatment and method of dung-water treatment
UA10998C2 (uk) Спосіб поліфакторhої лікувальhої дії та ковдра для поліфакторhої лікувальhої дії
GB2266241B (en) Treatment of pastures
ZA936136B (en) Treatment of skin diseases
GB9201391D0 (en) Method of treatment
HUT68145A (en) Procedure for the treatment and shaping of hair
AU7078691A (en) Use of urapidile and derivatives for treating arteriosclerotic diseases
GB9317989D0 (en) Treatment of laminitis
GB9207595D0 (en) Treatment of pastures
GB9212535D0 (en) Treatment of boimass
ZA968902B (en) Methods and compositions for treatment of diseases
GB9001029D0 (en) Method of treatment
GB9001031D0 (en) Method of treatment
GB9001028D0 (en) Method of treatment